Hinog, Kiara .

HRN: 22-39-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
CEFUROXIME 1.5GM (VIAL)
08/26/2023
09/02/2023
IVTT
190mg
Q8
ARTI
Checking Final Appropriateness 
08/27/2023
MUPIROCIN 2%, 15G (TUBE)
08/27/2023
09/03/2023
TOPICAL
1 Gram
TID
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: